About Contact Us Careers

VEGF Inhibitor Drugs Market Size

Request Free Sample Copy

Report ID: 2479
Published Date: Oct 09, 2024
Report Format: PDF, PPT

Buy Now

VEGF Inhibitor Drugs Market Size

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market size was over USD 9.45 billion in 2023 and is poised to exceed USD 34.2 billion by 2036, growing at over 10.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of vascular endothelial growth factor inhibitors is evaluated at USD 10.24 billion.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Report 2036

Author Credits: Radhika Pawar

Report ID: 2479
Published Date: Oct 09, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of cancer coupled with the rising demand for combination therapies are some of the major factors responsible for market growth.

The market is anticipated to attain a CAGR of 9% over the forecast period, i.e. 2020-2028.

Rising investments in research and development of VEGF inhibitor drugs and effective cancer therapies in North America will provide more business opportunities for market growth.

The major players in the global market are Pfizer, Inc., Novartis AG, GlaxoSmithKline plc, Sanofi, AstraZeneca plc, Bristol-Myers-Squibb Company, Genentech, Inc. (Roche), Merck & Co., Inc., Bayer AG and Eli Lilly & Company.

Inquiry Before Buying Request Free Sample